Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

256 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Antitumor necrosis factor treatment for pediatric inflammatory bowel disease.
de Bie CI, Escher JC, de Ridder L. de Bie CI, et al. Among authors: de ridder l. Inflamm Bowel Dis. 2012 May;18(5):985-1002. doi: 10.1002/ibd.21871. Epub 2011 Sep 20. Inflamm Bowel Dis. 2012. PMID: 21936033 Review.
Infliximab therapy in 30 patients with refractory pediatric crohn disease with and without fistulas in The Netherlands.
de Ridder L, Escher JC, Bouquet J, Schweizer JJ, Rings EH, Tolboom JJ, Houwen RH, Norbruis OF, Derkx BH, Taminiau JA. de Ridder L, et al. J Pediatr Gastroenterol Nutr. 2004 Jul;39(1):46-52. doi: 10.1097/00005176-200407000-00010. J Pediatr Gastroenterol Nutr. 2004. PMID: 15187780
Azathioprine maintains first remission in newly diagnosed pediatric Crohn's disease.
Jaspers GJ, Verkade HJ, Escher JC, de Ridder L, Taminiau JA, Rings EH. Jaspers GJ, et al. Among authors: de ridder l. Inflamm Bowel Dis. 2006 Sep;12(9):831-6. doi: 10.1097/01.mib.0000232470.00703.67. Inflamm Bowel Dis. 2006. PMID: 16954801
Infliximab as first-line therapy in severe pediatric Crohn disease.
de Ridder L, Benninga MA, Taminiau JA, Hommes DW. de Ridder L, et al. J Pediatr Gastroenterol Nutr. 2006 Sep;43(3):388-90. doi: 10.1097/01.mpg.0000226369.31956.bf. J Pediatr Gastroenterol Nutr. 2006. PMID: 16954965 No abstract available.
Genetic susceptibility has a more important role in pediatric-onset Crohn's disease than in adult-onset Crohn's disease.
de Ridder L, Weersma RK, Dijkstra G, van der Steege G, Benninga MA, Nolte IM, Taminiau JA, Hommes DW, Stokkers PC. de Ridder L, et al. Inflamm Bowel Dis. 2007 Sep;13(9):1083-92. doi: 10.1002/ibd.20171. Inflamm Bowel Dis. 2007. PMID: 17476680
Infliximab use in children and adolescents with inflammatory bowel disease.
de Ridder L, Benninga MA, Taminiau JA, Hommes DW, van Deventer SJ. de Ridder L, et al. J Pediatr Gastroenterol Nutr. 2007 Jul;45(1):3-14. doi: 10.1097/MPG.0b013e31803e171c. J Pediatr Gastroenterol Nutr. 2007. PMID: 17592358 Review.
Infliximab dependency in pediatric Crohn's disease: long-term follow-up of an unselected cohort.
de Ridder L, Rings EH, Damen GM, Kneepkens CM, Schweizer JJ, Kokke FT, Benninga MA, Norbruis OF, Hoekstra JH, Gijsbers CF, Escher JC. de Ridder L, et al. Inflamm Bowel Dis. 2008 Mar;14(3):353-8. doi: 10.1002/ibd.20329. Inflamm Bowel Dis. 2008. PMID: 18069674
Magnetic resonance enterography for suspected inflammatory bowel disease in a pediatric population.
Horsthuis K, de Ridder L, Smets AM, van Leeuwen MS, Benninga MA, Houwen RH, Littooij AS, Nievelstein RA, Stoker J. Horsthuis K, et al. Among authors: de ridder l. J Pediatr Gastroenterol Nutr. 2010 Nov;51(5):603-9. doi: 10.1097/MPG.0b013e3181dee5bd. J Pediatr Gastroenterol Nutr. 2010. PMID: 20890223
[Guideline 'Diagnosis and treatment of inflammatory bowel disease in children'].
de Ridder L, Rings EH, Escher JC; CBO-werkgroep ‘IBD bij kinderen’. de Ridder L, et al. Ned Tijdschr Geneeskd. 2010;154:A1898. Ned Tijdschr Geneeskd. 2010. PMID: 21029495 Dutch.
The duration of effect of infliximab maintenance treatment in paediatric Crohn's disease is limited.
De Bie CI, Hummel TZ, Kindermann A, Kokke FT, Damen GM, Kneepkens CM, Van Rheenen PF, Schweizer JJ, Hoekstra JH, Norbruis OF, Tjon A Ten WE, Vreugdenhil AC, Deckers-Kocken JM, Gijsbers CF, Escher JC, De Ridder L. De Bie CI, et al. Among authors: de ridder l. Aliment Pharmacol Ther. 2011 Jan;33(2):243-50. doi: 10.1111/j.1365-2036.2010.04507.x. Epub 2010 Nov 14. Aliment Pharmacol Ther. 2011. PMID: 21083595
256 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback